Tag: NASDAQ:PROK

Company

PROK’s -11.43% Loss This Week Has Revealed Something We Didn’t Know Before

During the last session, ProKidney Corp (NASDAQ:PROK)’s traded shares were 0.39 million, with the beta value of the company hitting 1.31. At the end of

Science

ProKidney Corp (NASDAQ: PROK) Slid -8.87% In 6 Months Getting Ready For What’s Next

ProKidney Corp (NASDAQ:PROK)’s traded shares stood at 0.43 million during the last session, with the company’s beta value hitting 1.31. At the close of trading,

Technologies

ProKidney Corp (NASDAQ: PROK): How Can A Stock Be Down -12.64% Year To Date, But Still Loser

ProKidney Corp (NASDAQ:PROK)’s traded shares stood at 1.16 million during the last session, with the company’s beta value hitting 1.30. At the close of trading,

Top Story

ProKidney Corp (NASDAQ:PROK): Buy, Sell Or Hold At $2.20?

In last trading session, ProKidney Corp (NASDAQ:PROK) saw 0.57 million shares changing hands with its beta currently measuring 1.11. Company’s recent per share price level

Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.

Tag: NASDAQ:PROK

PROK’s -11.43% Loss This Week Has Revealed Something We Didn’t Know Before

ProKidney Corp (NASDAQ: PROK) Slid -8.87% In 6 Months Getting Ready For What’s Next

ProKidney Corp (NASDAQ: PROK): How Can A Stock Be Down -12.64% Year To Date, But Still Loser

ProKidney Corp (NASDAQ:PROK): Buy, Sell Or Hold At $2.20?

Quick Links

Categories